secwatch.observer — SEC 8-K summary
======================================

Issuer:     Abpro Holdings, Inc. (ABPO)
CIK:        0001893219
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001213900-25-105590
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abpro/Celltrion present top-ranked preclinical data for CT-P72/ABP-102 at SITC 2025
--------------------------------------------------------------------------------

- Poster selected as Top 150 abstract out of >1,300 submissions at SITC 2025.
- CT-P72/ABP-102 shows potent anti-tumor activity in HER2-high models including Enhertu-resistant tumors.
- Dual-affinity engineering reduces off-tumor activation; favorable safety in monkeys up to 90 mg/kg.
- Data supports advancement toward first-in-human trial planned for next year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1893219/000121390025105590/0001213900-25-105590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1893219/000121390025105590/ea0263790-8k_abpro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-105590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer